<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02463669</url>
  </required_header>
  <id_info>
    <org_study_id>POCUSIM01</org_study_id>
    <nct_id>NCT02463669</nct_id>
  </id_info>
  <brief_title>The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department</brief_title>
  <official_title>The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jewish General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jewish General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if splenomegaly on point-of-care ultrasound (POCUS)&#xD;
      is an accurate and user-friendly surrogate to the heterophile antibody test and Epstein-Barr&#xD;
      Virus (EBV) serologies to diagnose acute mononucleosis infection in patients presenting with&#xD;
      sore throat to the Emergency Department (ED).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators seek to determine whether the presence of splenomegaly on POCUS can&#xD;
      accurately diagnose acute infectious mononucleosis in symptomatic ED patients, and determine&#xD;
      the feasibility of performing point-of-care ultrasound for splenomegaly by emergency&#xD;
      physicians in the emergency department setting.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    COVID pandemic&#xD;
  </why_stopped>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">October 4, 2020</completion_date>
  <primary_completion_date type="Actual">October 4, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of splenomegaly (maximal splenic cranio-caudal length) on point-of-care ultrasound</measure>
    <time_frame>12 months</time_frame>
    <description>Splenomegaly is defined as a splenic length of &gt; 11.5 centimetres (cm) for 10-12 year-old patients, &gt; 12 cm for 12-15 year-old patients, &gt; 12 cm for 15-35 year-old female patients, and &gt; 13 cm for 15-35 year-old male patients.</description>
  </primary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Infectious Mononucleosis</condition>
  <condition>Splenomegaly</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Point-of-care ultrasound</intervention_name>
    <description>Enrolled patients will undergo POCUS of the spleen by the treating emergency physician (resident, fellow or attending). Canadian Emergency Ultrasound Society (CEUS) certified residents, fellows and attending physicians will conduct the bedside ultrasonography after receiving specific training for the purposes of this study. The spleen will be assessed using a curved 2-6 Megahertz (MHz) transducer with the participant in the supine position. The cranio-caudal splenic length will be measured and its maximum dimension will be recorded on the standardized study data sheet.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Convenience sample of patients between July 2016 and October 2017. Inclusion criteria are&#xD;
        patients aged between 10 and 35 year-old presenting to the ED with suspected acute&#xD;
        infectious mononucleosis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged between 10 and 35 year-old presenting to the ED with suspected acute&#xD;
             infectious mononucleosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic infectious disorders (eg. tuberculosis, malaria, HIV, syphilis)&#xD;
&#xD;
          -  Inflammatory disorders (eg. sarcoidosis, amyloidosis, systemic lupus erythematosus,&#xD;
             Felty syndrome)&#xD;
&#xD;
          -  Proliferative disorders (eg. lymphoma, leukemia, essential thrombocytopenia,&#xD;
             polycythemia vera)&#xD;
&#xD;
          -  Congestive disorders (eg: cirrhosis, portal hypertension, right heart failure,&#xD;
             congenital heart disease)&#xD;
&#xD;
          -  Chronic haemolytic anemia (eg. sickle cell, thalassemia, hereditary spherocytosis)&#xD;
&#xD;
          -  Storage diseases (eg. Gaucher, Niemann-Pick)&#xD;
&#xD;
          -  Splenectomy&#xD;
&#xD;
          -  Inability to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Sainte-Justine</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jewish General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 31, 2015</study_first_submitted>
  <study_first_submitted_qc>June 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2015</study_first_posted>
  <last_update_submitted>October 4, 2020</last_update_submitted>
  <last_update_submitted_qc>October 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jewish General Hospital</investigator_affiliation>
    <investigator_full_name>Laurie Robichaud</investigator_full_name>
    <investigator_title>Laurie Robichaud, MD</investigator_title>
  </responsible_party>
  <keyword>Point-of-care ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
    <mesh_term>Infectious Mononucleosis</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Splenomegaly</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

